Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. The study “Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis”, published in Journal of Orthopaedic Research this month, has been designed to identify clinical and radiological Read more…
Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62 (36-87) BMI 25,4 (17,9-41,8) Read more…
LABRHA participated at the ACR Congress in Washington DC, which took place from the 11th to the 16th of November 2016, and displayed a poster presenting the results of a study conducted to identify the clinical and radiological factors associated with a lack of a relevant response to viscosupplementation (VS) Read more…
Imaging guidance improves the results of viscosupplementation with HANOX-M-XL in patients with ankle osteoarthritis. Results of a clinical survey in 50 patients treated in daily practice. M. Bossert; D. Boulbil; JM Parisaux; AM Bozgan; E. Richelme; T. Conrozier. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2016:9 195–199 doi: 10.4137/CMaMd.s40401. . Read more…
LABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. For the third consecutive year, LABRHA organised last 15th and 16th of September in Lyon, a new edition of the LABRHA European Board on Viscosupplementation. For this 3rd edition, the task group Read more…